Discover
ACRS
Aclaris Therapeutics, Inc.
5.34
2 x 4.03
2 x 6.74
bid
ask
+
0.05
0.95%
2 @ 05:58 AM
5.24 -0.10 (1.87%)
| Ytd | 77.41% | |
| 1y | 278.72% |
5.24
day range
5.69
1.39
52 week range
5.69
| Open | 5.59 | Prev Close | 5.29 | Low | 5.24 | High | 5.69 | Mkt Cap | 745.80M |
| Vol | 2.39M | Avg Vol | 1.53M | EPS | -0.56 | P/E | N/A | Forward P/E | -5.00 |
| Beta | 0.12 | Short Ratio | 0.47 | Inst. Own | 90.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.59 | 200-d Avg | 3.36 | 1yr Est | 10.00 |
ACRS News
zacks.com
Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength?
Aclaris (ACRS) witnessed a jump in share price last session on above-average trading volume. The lat
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
benzinga.com
SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures mixed. SL Science shares fall 11.4% after reporting financial results. Other stoc
benzinga.com
This Piper Sandler Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations From Tuesda
Top Wall Street analysts begin coverage of Aclaris Therapeutics, Orion Group Holdings, and Take-Two